Mayo Clinic Hospitalist added to Board of Advisors for Drug Diversion Prevention Company

Drug diversion prevention company ANiGENT has added a hospital leader to serve on its Board of Advisors (BOA). Kenneth J. Mishark, MD, from Mayo Clinic Hospital in Arizona, will sit on the board and provide insights on how ANiGENT can better serve healthcare organizations.

ANiGENT is the first and only software provider to deliver a comprehensive solution that helps facilities track and monitor potential drug diversion among all users and all drugs in all locations. Its proprietary drug diversion prevention software is the result of a 5-year benchmarking study.
“Dr. Mishark will be an invaluable asset to our board,” said V.C. “Jun” Fabella, Jr., chief executive officer and managing partner of ANiGENT. “His expertise in leadership and experience overseeing a hospital drug diversion prevention program will allow us to enhance our platform and further prevent drug diversion.”

ABOUT ANiGENT

ANiGENT, is a company that delivers a comprehensive, patent pending solution Medication Administration & Analysis Program (MAAP). Created by chief product officer and managing partner Charles D’Amato, MAAP Analytics uses machine learning to deliver a state-of-the-art drug diversion surveillance system. For more information, visit: anigent.com

Article Link

Tags:

National Association of Drug Diversion Investigators Federal Tax ID: 52-1660752 / DUNS Number: 073539913

Copyright © 2022 - NADDI. All Rights Reserved. Privacy Policy / Trademark Policy / Copyright Policy / Refund Policy

Log in with your credentials

or    

Forgot your details?

Create Account